Drug reference
Primary Raynaud’s syndrome (short-term treatment) ▶BY MOUTH ▶Adult: Initially 40 mg 4 times a day, increased if necessary to 80 mg 4 times a day, increase dose if poor initial response, discontinue after 2 weeks if no response
PDF page 269
Diabetes mellitus
PDF page 269
→Appendix 1: moxisylyte
PDF page 269
▶Rare or very rare Hepatic disorders. rash ▶Frequency not known Diarrhoea. flushing. headache. nausea. vertigo
PDF page 269
Manufacturer advises avoid.
PDF page 269
Manufacturer advises avoid in active liver disease. l LESS SUITABLE FOR PRESCRIBING Less suitable for prescribing.
PDF page 269
There can be variation in the licensing of different medicines containing the same drug. Tablet CAUTIONARY AND ADVISORY LABELS 21 ▶Opilon (Kyowa Kirin Ltd) Moxisylyte (as Moxisylyte hydrochloride) 40 mg Opilon 40mg tablets | 112 tablet P £90.22 DT = £90.22
PDF page 269
Initially 40 mg 4 times a day, increased if
First-line fragment. Read the complete Indications and Dose section above.
PDF page 269
